Dedifferentiated Liposarcoma — Trials

Dedifferentiated Liposarcoma — Trials · CancerIndex

Clinical trials

Registered studies

35 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 19
Recruiting: 9
Ph III recruiting: 1
Growth YoY: —
Industry share: 16%
Top sponsor: Memorial Sloan Kettering Cancer Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (5)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07802652	Doxorubicin With or Without DT-7012 in Advanced Soft Tissue Sarcoma(IMMUSARC-7012)	not yet recruiting	Phase 2	80	Gustave Roussy, Cancer Campus, Grand ParisOTHER	1	Sep 15, 2026	clinicaltrials
NCT07741877	A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Soft Tissue Sarcoma('SARATOGA')	not yet recruiting	Phase 2	80	Iovance Biotherapeutics, Inc.INDUSTRY	0